Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Thumbnail

Infographic: Are we missing the mark on cancer screening targets?

Recommended cancer screenings have been shown to increase early diagnosis and save lives in at-risk patient populations. A government initiative called Healthy People 2020 includes targets for increasing screening levels for breast and colorectal cancer over the next five years to improve cancer survival and overall public health, but progress updates are necessary to ensure that such targets are within reach. 

Risk of cancer related to parathyroid imaging negligible for both 4D CT and scintigraphy

The lifetime risk of developing cancer following parathyroid imaging using either 4D CT or scintigraphy is negligible and should not deter doctors from utilizing the modalities for preoperative assessments, according to study results published in the May issue of the American Journal of Roegentology.

Thumbnail

Cracking the code for pancreatic cancer screening

Pancreatic cancer presents an imposing foe. Mortality is high, owing to the fact that many cases are diagnosed late stage, yet routine screening of those at average risk is not practical. The key will be targeting screening to those at high risk, and one of this week’s top stories featured the short-term results of a small screening program that did just that.

Study shows promise of MRI-based screening for pancreatic cancer

Short-term results of an MRI-based screening program for patients at high risk of pancreatic cancer, published online in JAMA Surgery, showed the program was able to identify pancreatic lesions in 40 percent of patients, ultimately leading to surgery in five patients.

‘Tumor paint’ could help surgeons treat brain cancer

Tumor paint, a substance derived from scorpion venom that can cross the blood-brain barrier, can make brain tumors glow under near-infrared light, making them easier targets for surgeons.

Annual cancer report shows decline in mortality rates, analyzes breast cancer subtypes

Overall rates for cancer deaths are decreasing among all demographics nationwide, according to “The Annual Report to the Nation on the Status of Cancer, 1975-2011.” The report, published Mar. 30 in the Journal of the National Cancer Institute, also analyzed breast cancer subtypes for the first time ever. 

MRI based on a sugar molecule can tell cancerous from noncancerous cells

Imaging tests like mammograms or CT scans can detect tumors, but figuring out whether a growth is or isn’t cancer usually requires a biopsy to study cells directly. Now results of a Johns Hopkins study suggest that MRI could one day make biopsies more effective or even replace them altogether by noninvasively detecting telltale sugar molecules shed by the outer membranes of cancerous cells.

Thumbnail

Fatty acids in fish oil could cut chemo effectiveness

Consuming herring, mackerel, or certain dietary supplements containing fish oils can induce resistance to chemotherapy and limit the impact treatment has on tumor growth, according to a study published online in JAMA Oncology.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.